Phase I Study of RiMO-301 With Radiation in Advanced Tumors
Clinical trial NCT03444714 · COMPLETED
Trial details
- NCT number
- NCT03444714
- Sponsor
- Coordination Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2025-06-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.